Summary
- Current Price
- As of today, AQST price is $4.99, down -3.11% on
- Current Price All-Time High
- AQST price is currently -75.89% below its historical high of $20.70 set on
- Market Cap
- AQST current market cap is $626M, up +27.35% over the past 365 days
- Revenue
- AQST current annual revenue is $44.55M, down -22.61% year-over-year
- Next Earnings
- The next earnings release for AQST is on
Profile
| Metric | Value |
|---|---|
| Full Name | Aquestive Therapeutics, Inc. |
| Ticker | NASDAQ: AQST |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Specialty & Generic Drug Manufacturers |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | aquestive.com |
| Employees | 142 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $4.99 | |
| Price, 1D Change | -3.11% | |
| $626M | ||
| - | ||
| - | ||
| 0.93 | ||
| $44.55M | ||
| Revenue, 1Y Change | -22.61% | |
| -$0.78 | ||
| EPS, 1Y Change | -53.98% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$0.78 | ||
| EPS Estimate | -$0.45 | N/A |
| EPS Est. Change | +42.57% | N/A |
| $44.55M | ||
| Revenue Estimate | $49.93M | N/A |
| Revenue Est. Change | +12.09% | N/A |
| Current Price | $4.99 | |
| Price Target | $10.00 | - |
| Price Tgt. Change | +100.40% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.42 | -$0.51 | -20.45% | |
| -$0.59 | -$0.78 | -32.81% | |
| -$0.45 | N/A | +42.57% | |
| -$0.57 | N/A | +27.26% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $57.50M | $57.56M | +0.11% | |
| $44.81M | $44.55M | -0.59% | |
| $49.93M | N/A | +12.09% | |
| $67.77M | N/A | +52.14% |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $4.99 | |
| $4.45 | ||
| $4.36 | ||
| $4.40 | ||
| $4.56 | ||
| $0.27 | ||
| 0.93 | ||
| $0.25 | ||
| 56.10 | ||
| 38.92% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $44.55M | ||
| -$0.78 | ||
| $25.99M | ||
| 58.35% | ||
| -$71.05M | ||
| -159.50% | ||
| -$83.78M | ||
| -188.09% | ||
| -$70.49M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| -3.90 | ||
| 3.14 | ||
| 3.01 | ||
| - | ||
| 3 | ||
| -2.36 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| 11.58 | ||
| -11.07 | ||
| -12.96 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| -$33.66M | ||
| $121.17M | ||
| $162.17M | ||
| $149.27M | ||
| $195.83M | ||
| $47.61M | ||
| $131.45M | ||
| $11.63M | ||
| $29.86M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $128.33M | ||
| $97.04M | ||
| $18.56M | ||
| $0.00 | ||
| $548.00K | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$52.43M | ||
| -$562.00K | ||
| $102.62M | ||
| $562.00K | ||
| -$52.99M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| HC Wainwright & Co. | → | |
| Piper Sandler | → | |
| JMP Securities | → | |
| Oppenheimer | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| Lake Street | → | |
| HC Wainwright & Co. | → |
Analyst sentiment
Institutional ownership
Screeners with AQST
FAQ
- What is the ticker symbol for Aquestive Therapeutics, Inc.?
- The ticker symbol for Aquestive Therapeutics, Inc. is NASDAQ:AQST
- Does Aquestive Therapeutics, Inc. pay dividends?
- No, Aquestive Therapeutics, Inc. does not pay dividends
- What sector is Aquestive Therapeutics, Inc. in?
- Aquestive Therapeutics, Inc. is in the Healthcare sector
- What industry is Aquestive Therapeutics, Inc. in?
- Aquestive Therapeutics, Inc. is in the Specialty & Generic Drug Manufacturers industry
- What country is Aquestive Therapeutics, Inc. based in?
- Aquestive Therapeutics, Inc. is headquartered in United States
- When did Aquestive Therapeutics, Inc. go public?
- Aquestive Therapeutics, Inc. initial public offering (IPO) was on July 25, 2018
- Is Aquestive Therapeutics, Inc. in the S&P 500?
- No, Aquestive Therapeutics, Inc. is not included in the S&P 500 index
- Is Aquestive Therapeutics, Inc. in the NASDAQ 100?
- No, Aquestive Therapeutics, Inc. is not included in the NASDAQ 100 index
- Is Aquestive Therapeutics, Inc. in the Dow Jones?
- No, Aquestive Therapeutics, Inc. is not included in the Dow Jones index
- When was Aquestive Therapeutics, Inc. last earnings report?
- Aquestive Therapeutics, Inc.'s most recent earnings report was on August 11, 2026
- When does Aquestive Therapeutics, Inc. report earnings?
- The next expected earnings date for Aquestive Therapeutics, Inc. is November 4, 2026
Data Sources & References
- AQST Official Website www.aquestive.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1398733/000139873326000018/0001398733-26-000018-index.htm
- AQST Profile on Yahoo Finance finance.yahoo.com/quote/AQST
- AQST Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/aqst